Evidence map›Paper›PMID 33336881›Full record

ArticleESC heart failure2021

Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions.

Anuradha Lala, Maya H Barghash, Gennaro Giustino, Jesus Alvarez-Garcia, Swiri Konje, Aditya Parikh, Jennifer Ullman, Brendan Keith, John Donehey, Sumeet S Mitter and 6 more

2 registry-linked trialsOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05405504 unknown statusnot on this mapstarted 2022, after this paper: background citation

Evaluation of ReDS Pro System V2.7 and ReDS ICU in Patients With Heart Failure

TypeobservationalSponsorChristian HassagerRan2022 to 2024Enrolled25ConditionsHeart FailureArmsRemote Dielectric Sensing (ReDS)
NCT07484009 narecruitingnot on this mapstarted 2026, after this paper: background citation

ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure: the ReDS-SAFE HF II Trial

TypeinterventionalSponsorFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalRan2026 to 2027Enrolled1,014ConditionsAcute Heart Failure (AHF), Heart Failure (for Example, Fluid Overload), Heart Failure HospitalizationArmsRemote Dielectric Sensing System, Blinded ReDS data
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Biomarkers of Hemodynamic Congestion in Heart Failure.Current heart failure reports · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Anuradha LalaZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Maya H BarghashZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Gennaro GiustinoZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Jesus Alvarez-GarciaZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.ORCID 0000-0002-2015-6446
Swiri KonjeMount Sinai, St. Luke's Hospital, New York, NY, USA.
Aditya ParikhZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Jennifer UllmanZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Brendan KeithZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
John DoneheyZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Sumeet S MitterZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Maria Giovanna TrivieriZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Johanna P ContrerasCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Daniel BurkhoffCardiovascular Research Foundation, NY, New York, USA.
Noah MossZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Donna M ManciniZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, PO Box 1030, New York, NY, 10129, USA.
Sean P PinneyUniversity of Chicago Medicine, Duchossois Center for Advanced Medicine (DCAM), Hyde Park, 5758 S. Maryland Ave., Chicago, IL, 60637.
Mount Sinai Hospital · USUniversitat Autònoma de Barcelona · ESCardiovascular Research Foundation · USMount Sinai Hospital · USUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsReadmission after hospitalization for acute decompensated heart failure (HF) remains a major public health problem. Use of remote dielectric sensing (ReDS) to measure lung water volume allows for an objective assessment of volume status and may guide medical optimization for HF. We hypothesized that the use of ReDS would lower 30 day readmission in patients referred to rapid follow-up (RFU) clinic after HF discharge. METHODS AND

resultsWe conducted a retrospective analysis of the use of ReDS for patients scheduled for RFU within 10 days post-discharge for HF at Mount Sinai Hospital between 1 July 2017 and 31 July 2018. Diuretics were adjusted using a pre-specified algorithm. The association between use of ReDS and 30 day readmission was evaluated. A total of 220 patients were included. Mean age was 62.9 ± 14.7 years, and 36.4% were female. ReDS was performed in 80 (36.4%) and led to medication adjustment in 52 (65%). Use of ReDS was associated with a lower rate of 30 day cardiovascular readmission [2.6% vs. 11.8%, hazard ratio (HR): 0.21; 95% confidence interval (CI): 0.05-0.89; P = 0.04] and a trend towards lower all-cause readmission (6.5% vs. 14.1%, HR: 0.43; 95% CI: 0.16-1.15; P = 0.09) as compared with patients without a ReDS assessment.

conclusionsReDS-guided HF therapy during RFU after HF hospitalization may be associated with lower risk of 30 day readmission.

Indexed as

Heart FailurePatient ReadmissionAftercareAgedFemaleHospitalizationHumansMiddle AgedPatient DischargeRetrospective StudiesCongestionHeart failureReadmissionsRemote dielectric sensing

Identifiers

PMID33336881
PMCPMC8006703
OpenAlexW3113646613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.